These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15162426)
1. Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells. Barnes E; Ward SM; Kasprowicz VO; Dusheiko G; Klenerman P; Lucas M Eur J Immunol; 2004 Jun; 34(6):1570-7. PubMed ID: 15162426 [TBL] [Abstract][Full Text] [Related]
2. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760 [TBL] [Abstract][Full Text] [Related]
3. The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. López-Labrador FX; He XS; Berenguer M; Cheung RC; Wright TL; Greenberg HB J Immunol Methods; 2004 Apr; 287(1-2):91-9. PubMed ID: 15099758 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers. Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644 [TBL] [Abstract][Full Text] [Related]
5. Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Abel M; Sène D; Pol S; Bourlière M; Poynard T; Charlotte F; Cacoub P; Caillat-Zucman S Hepatology; 2006 Dec; 44(6):1607-16. PubMed ID: 17133491 [TBL] [Abstract][Full Text] [Related]
6. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection]. Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781 [TBL] [Abstract][Full Text] [Related]
7. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959 [TBL] [Abstract][Full Text] [Related]
8. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596 [TBL] [Abstract][Full Text] [Related]
9. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286 [TBL] [Abstract][Full Text] [Related]
10. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection. Boni C; Amadei B; Urbani S; Fisicaro P; Zerbini A; Mori C; Missale G; Bertoni R; Azzurri A; Del Prete G; Ferrari C Hepatology; 2004 Aug; 40(2):289-99. PubMed ID: 15368433 [TBL] [Abstract][Full Text] [Related]
11. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989 [TBL] [Abstract][Full Text] [Related]
12. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment. Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536 [TBL] [Abstract][Full Text] [Related]
13. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C. Sobao Y; Tomiyama H; Nakamura S; Sekihara H; Tanaka K; Takiguchi M Hepatology; 2001 Jan; 33(1):287-94. PubMed ID: 11124847 [TBL] [Abstract][Full Text] [Related]
14. Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes. Komatsu H; Lauer G; Pybus OG; Ouchi K; Wong D; Ward S; Walker B; Klenerman P J Viral Hepat; 2006 Feb; 13(2):121-30. PubMed ID: 16436130 [TBL] [Abstract][Full Text] [Related]
15. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525 [TBL] [Abstract][Full Text] [Related]
16. Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome. Racanelli V; Manigold T Clin Immunol; 2007 Jul; 124(1):5-12. PubMed ID: 17540619 [TBL] [Abstract][Full Text] [Related]
17. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288 [TBL] [Abstract][Full Text] [Related]
18. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Pilli M; Penna A; Zerbini A; Vescovi P; Manfredi M; Negro F; Carrozzo M; Mori C; Giuberti T; Ferrari C; Missale G Hepatology; 2002 Dec; 36(6):1446-52. PubMed ID: 12447871 [TBL] [Abstract][Full Text] [Related]